Anaergia Inc (ANRGF) Fair Value & Analysis
Industrials · US · Market cap $319M
Fair value as of: Jun 24, 2026
Analysis
Anaergia Inc (ANRGF) currently trades at $1.88, while our model-based Fair Value estimate is $0.4800 — implying the stock looks roughly 74.5% overvalued today. We read business quality at 80/100 (high quality), in the Industrials sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: medium).
About the company
Anaergia Inc., together with its subsidiaries, provides solutions for the generation of renewable energy and conversion of waste to resources in Italy, North America, Europe, the Middle East and Africa, and the Asia Pacific. It operates through three segments: Capital Sales; Operation & Maintenance Services; and Build, Own, and Operate. The company offers OREX, a waste processing solution that capture and process organic waste contained within mixed municipal solid wastes; Omnivore anaerobic digestion to produce valuable biogas and a nutrient rich soil amendment byproduct; membrane-based system to upgrade biogas and create pipeline; liquid treatment for water re-use and nutrient recovery; and residue treatment solutions. It provides wastewater resource recovery, municipal solid waste, and agricultural waste solutions. Anaergia Inc. was founded in 2007 and is headquartered in Burlington, Canada.
Open the full interactive analysis →
Similar stocks
Frequently asked questions
Is Anaergia Inc (ANRGF) undervalued?
What is the fair value of ANRGF?
What is the quality score of ANRGF?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.